Emerson FY26 Q3 GAAP EPS rises 24% to $1.28; net sales increase 7% to $4.87 billion
E
EMR• Fiscal third-quarter results
- Emerson fiscal Q3 GAAP EPS rose 24% to USD 1.28, as net sales climbed 7% to USD 4.87 billion.
- Pretax earnings increased to USD 916 million, lifting pretax margin 2.7 percentage points to 18.8%.
- Operating cash flow jumped 34% to USD 1.43 billion; free cash flow rose 36% to USD 1.32 billion.
Orders, regional sales and guidance
- Underlying orders increased 7%, led by Software & Systems; sales rose 8% in the Americas and 8% in Asia, Middle East & Africa.
- Emerson raised fiscal 2026 guidance to about USD 4.89 GAAP EPS and about USD 6.55 adjusted EPS, projecting about USD 3.6 billion free cash flow.
SU
•
Emerson FY26 Q3 GAAP EPS rises 24% to $1.28; net sales increase 7% to $4.87 billion - EMR News | Rallies
